Can-Fite: FDA Grants IND Clearance for Namodenoson to Treat Patients with MASH in Phase IIb Study

Business Wire

RAMAT GAN, Israel, May 9, 2024–(BUSINESS WIRE)–Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing a portfolio of proprietary small molecule drugs that treat oncology and inflammatory diseases, …

Read more

Celebrating Utah moms with new efforts to treat maternal mental illness

Celebrating Utah moms with new efforts to treat maternal mental illness

As Americans celebrate the mothers in our lives, health care professionals here in Utah are increasing their commitment to improving treatment and understanding of the mental health challenges women experience …

Read more